301 related articles for article (PubMed ID: 32798911)
1. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
[TBL] [Abstract][Full Text] [Related]
2. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
Anor CJ; Dadar M; Collins DL; Tartaglia MC
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
[TBL] [Abstract][Full Text] [Related]
3. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.
Ozzoude M; Varriano B; Beaton D; Ramirez J; Adamo S; Holmes MF; Scott CJM; Gao F; Sunderland KM; McLaughlin P; Goubran M; Kwan D; Roberts A; Bartha R; Symons S; Tan B; Swartz RH; Abrahao A; Saposnik G; Masellis M; Lang AE; Marras C; Zinman L; Shoesmith C; Borrie M; Fischer CE; Frank A; Freedman M; Montero-Odasso M; Kumar S; Pasternak S; Strother SC; Pollock BG; Rajji TK; Seitz D; Tang-Wai DF; Turnbull J; Dowlatshahi D; Hassan A; Casaubon L; Mandzia J; Sahlas D; Breen DP; Grimes D; Jog M; Steeves TDL; Arnott SR; Black SE; Finger E; Rabin J; ; Tartaglia MC
Alzheimers Res Ther; 2023 Jun; 15(1):114. PubMed ID: 37340319
[TBL] [Abstract][Full Text] [Related]
5. Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
Chan CK; Pettigrew C; Soldan A; Zhu Y; Wang MC; Albert M; Rosenberg PB;
J Alzheimers Dis; 2022; 86(3):1415-1426. PubMed ID: 35213370
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
7. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
8. Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment.
Zhu W; Huang H; Yang S; Luo X; Zhu W; Xu S; Meng Q; Zuo C; Liu Y; Wang W;
Neurosci Bull; 2021 Jun; 37(6):789-803. PubMed ID: 33826095
[TBL] [Abstract][Full Text] [Related]
9. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
[TBL] [Abstract][Full Text] [Related]
10. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
[TBL] [Abstract][Full Text] [Related]
11. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
Dadar M; Manera AL; Ducharme S; Collins DL
Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
[TBL] [Abstract][Full Text] [Related]
13. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
[TBL] [Abstract][Full Text] [Related]
15. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518
[TBL] [Abstract][Full Text] [Related]
16. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
[TBL] [Abstract][Full Text] [Related]
18. Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment.
Calcetas AT; Thomas KR; Edmonds EC; Holmqvist SL; Edwards L; Bordyug M; Delano-Wood L; Brickman AM; Bondi MW; Bangen KJ; For The Alzheimer's Disease Neuroimaging Initiative
Neurobiol Aging; 2022 Oct; 118():1-8. PubMed ID: 35809348
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensities and mild behavioral impairment: Findings from the MEMENTO cohort study.
Miao R; Chen HY; Robert P; Smith EE; Ismail Z;
Cereb Circ Cogn Behav; 2021; 2():100028. PubMed ID: 36324720
[TBL] [Abstract][Full Text] [Related]
20. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
